News
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
The Associated Press on MSN6d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
StockStory.org on MSN1d
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5% ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results